Kupffer cell-like syncytia replenish resident macrophage function in the fibrotic liver.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
08 09 2023
Historique:
medline: 11 9 2023
pubmed: 7 9 2023
entrez: 7 9 2023
Statut: ppublish

Résumé

Kupffer cells (KCs) are localized in liver sinusoids but extend pseudopods to parenchymal cells to maintain their identity and serve as the body's central bacterial filter. Liver cirrhosis drastically alters vascular architecture, but how KCs adapt is unclear. We used a mouse model of liver fibrosis and human tissue to examine immune adaptation. Fibrosis forced KCs to lose contact with parenchymal cells, down-regulating "KC identity," which rendered them incapable of clearing bacteria. Commensals stimulated the recruitment of monocytes through CD44 to a spatially distinct vascular compartment. There, recruited monocytes formed large aggregates of multinucleated cells (syncytia) that expressed phenotypical KC markers and displayed enhanced bacterial capture ability. Syncytia formed via CD36 and were observed in human cirrhosis as a possible antimicrobial defense that evolved with fibrosis.

Identifiants

pubmed: 37676943
doi: 10.1126/science.abq5202
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabq5202

Auteurs

Moritz Peiseler (M)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow Klinikum and Campus Charité Mitte, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.

Bruna Araujo David (B)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Joel Zindel (J)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Visceral Surgery and Medicine, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.

Bas G J Surewaard (BGJ)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Woo-Yong Lee (WY)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Felix Heymann (F)

Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow Klinikum and Campus Charité Mitte, Berlin, Germany.

Ysbrand Nusse (Y)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Fernanda V S Castanheira (FVS)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Raymond Shim (R)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Adrien Guillot (A)

Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow Klinikum and Campus Charité Mitte, Berlin, Germany.

Alix Bruneau (A)

Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow Klinikum and Campus Charité Mitte, Berlin, Germany.

Jawairia Atif (J)

Ajmera Transplant Centre, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.

Catia Perciani (C)

Ajmera Transplant Centre, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.

Christina Ohland (C)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Priyanka Ganguli Mukherjee (P)

Department of Cell Biology and Anatomy, University of Calgary, Calgary, Alberta, Canada.

Annika Niehrs (A)

Leibniz Institute of Virology (LIV), Hamburg, Germany.

Roland Thuenauer (R)

Leibniz Institute of Virology (LIV), Hamburg, Germany.

Marcus Altfeld (M)

Leibniz Institute of Virology (LIV), Hamburg, Germany.

Mathias Amrein (M)

Department of Cell Biology and Anatomy, University of Calgary, Calgary, Alberta, Canada.

Zhaoyuan Liu (Z)

Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Paul M K Gordon (PMK)

Centre for Health Genomics and Informatics, University of Calgary, Calgary, Alberta, Canada.

Kathy McCoy (K)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Justin Deniset (J)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.
Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Sonya MacParland (S)

Ajmera Transplant Centre, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.

Florent Ginhoux (F)

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Gustave Roussy Cancer Campus, INSERM U1015, Villejuif, France.

Frank Tacke (F)

Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow Klinikum and Campus Charité Mitte, Berlin, Germany.

Paul Kubes (P)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH